Private investors: FCPI

Investing in innovative SMEs, supporting growth and employment

Channel individual savings into innovative start-ups

  • FCPI (funds dedicated to innovative companies) are funds approved by the AMF that allow individual investors to invest in up-and-coming and innovative unlisted companies.
  • This asset class presents liquidity and loss of capital risks

Invest in technology and life sciences

  • Omnes Capital Venture Capital team manages €700 million in assets under management. For over 20 years, it has successfully supported dynamic and innovative companies in the digital and health sectors.

Benefit from tax incentives

  • Reduces your income tax by an amount equivalent to 18% of your investment (excl. entry charges) up to €2,160 for a single individual (for a maximum investment excl. entry charges of €12,000) or up to €4,320 for a married couple (for an investment of €24,000 excl. entry charges).
    For an investment of €10,000, the incentive works out at 10,000 x 18%, i.e. €1,800
  • In return for blocking assets over a period of 8 years, extendable by 1 year by decision of the management company
FCPI managed by Omnes Capital

Net asset values of Omnes Capital FCPI
> Download the document (French only)

 

The performance of a private equity fund is appreciated over a long investment period. The Net Asset Value may not reflect the potential of the portfolio assets over the life of the Fund and may not reflect the potential evolution of their fair value.

Key figures
20
years’
experience
€700
million
in assets under management
21
FCPI under management
24,000
clients
NewsRoom
Press release
11 June 2020
Omnes brings on board an Analyst, an Associate, a Principal, an Asset Management Director and a Financial Controller; Omnes also has promoted an Associate and two Principals.
Omnes brings on board an Analyst, an Associate, a Principal, an Asset Management Director and a Financial Controller; Omnes also has promoted an Associate and two Principals.
La Fondation Omnes supports e-Enfance
Publication
Scope, the Omnes review, December 2019
Press release
04 June 2020
Capenergie 4 fund signs two new investments in Europe
Capenergie 4 fund signs two new investments in Europe
Job offer
Discover our job offers on Linkedin
5 years 3 months ago
Logo reveal video
Press release
20 May 2020
Omnes invests Biofutur, a group of medical biology laboratories
Omnes invests Biofutur, a group of medical biology laboratories

Pages